Titan Pharmaceuticals, Inc.

281 articles about Titan Pharmaceuticals, Inc.

• Titan Pharmaceuticals Reports Second Quarter 2007 Results

  8/2/2007

• Titan Pharmaceuticals Annnounces Completion of Patient Enrollment in Randomized Phase IIb Clinical Study of Spheramine(R) In Parkinson's Disease

  6/28/2007

• Titan Pharmaceuticals Reports First Quarter 2007 Results

  5/9/2007

• Titan Pharmaceuticals to Raise $11 Million in Registered Direct Offering of Common Stock

  4/25/2007

• Titan Pharmaceuticals Announces Equity Financing Commitment of up to $25 Million

  3/16/2007

• Titan Pharmaceuticals Announces Termination of Equity Financing Agreement with Cornell Capital Partners

  3/14/2007

• Titan Pharmaceuticals Reports Fourth Quarter and Year End 2006 Results

  3/5/2007

• Titan Pharmaceuticals Reports Positive Results In Iloperidone Phase III Clinical Trial

  12/8/2006

• Titan Pharmaceuticals Reports Positive Results In Iloperidone Phase III Clinical Trial

  12/7/2006

• Titan Pharmaceuticals Reports Third Quarter 2006 Results

  11/9/2006

• Titan Pharmaceuticals Initiates Phase III Development Program For Probuphine(R) In The Treatment Of Opioid Dependence

  10/25/2006

• The Day In Review: Icahn Takes Over As ImClone Systems Incorporated Chairman

  10/25/2006

• Titan Pharmaceuticals Reports Second Quarter 2006 Results

  8/9/2006

• Titan Pharmaceuticals To Raise $10 Million In Registered Direct Offering Of Common Stock

  3/16/2006

• Titan Pharmaceuticals Reports Fourth Quarter And Year End 2005 Results

  3/14/2006

• Titan Pharmaceuticals Initiates Controlled Phase II Clinical Study Of DITPA In The Treatment Of Elevated Cholesterol Levels

  3/7/2006

• Titan Pharmaceuticals Announces Favorable Results Of Pilot Clinical Study Of Spheramine(R) Reported In Archives Of Neurology

  12/15/2005

• Titan Pharmaceuticals Announces That Vanda Pharmaceuticals, Inc. Initiates Phase III Clinical Trial Of Iloperidone

  12/12/2005

• Titan Pharmaceuticals Reports Third Quarter 2005 Results

  11/9/2005

• Promising Technologies 5C: Stem Cell Companies

  7/14/2005